Variant report

Variant	nsv551031
Chromosome Location	chr10:57004863-57036663
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:55757466..55757977-chr10:57022925..57023910,2	MCF-7	breast:
2	chr10:56856112..56857067-chr10:57023573..57024305,2	MCF-7	breast:
3	chr10:57012609..57015608-chr6:34209555..34212466,2	K562	blood:
4	chr10:56851202..56852127-chr10:57023430..57024403,6	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZWINT-4	chr10:57007515-57007648	ENSG00000236744.2
2	lnc-ZWINT-4	chr10:57007508-57007648	ENSG00000236744.1

No data

Extended variants
information (count: 464 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:464 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145220093	chr10:57005402-57005403	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs74136402	chr10:57005450-57005451	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs374697358	chr10:57005542-57005543	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs375825571	chr10:57005554-57005555	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs368907141	chr10:57005647-57005648	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs73269635	chr10:57005663-57005664	Active TSS Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs571831763	chr10:57005698-57005699	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs140896775	chr10:57005715-57005716	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs557640112	chr10:57005844-57005845	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs574289470	chr10:57005914-57005915	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs538567035	chr10:57005918-57005919	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs370037250	chr10:57005958-57005959	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs543343078	chr10:57005981-57005982	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs184585230	chr10:57006028-57006029	Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs573261040	chr10:57006052-57006053	Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs545535956	chr10:57006059-57006060	Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs188956731	chr10:57006082-57006083	Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs558783823	chr10:57006120-57006121	Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs182132847	chr10:57006225-57006226	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs185525200	chr10:57006265-57006266	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs529395953	chr10:57006339-57006340	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs368520492	chr10:57006379-57006380	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs2044319	chr10:57006402-57006403	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs190345746	chr10:57006403-57006404	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs140398030	chr10:57006479-57006480	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs545247987	chr10:57006509-57006510	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs113167399	chr10:57006572-57006573	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs559731839	chr10:57006607-57006608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs143791224	chr10:57006735-57006736	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs551856159	chr10:57006758-57006759	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs148140309	chr10:57006762-57006763	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs372202910	chr10:57006796-57006797	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs537933937	chr10:57006807-57006808	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs550942738	chr10:57006811-57006812	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs567828451	chr10:57006813-57006814	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs536981361	chr10:57006854-57006855	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs553670589	chr10:57006887-57006888	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs141922067	chr10:57006927-57006928	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs538988626	chr10:57006944-57006945	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs150696449	chr10:57006950-57006951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs181079918	chr10:57006954-57006955	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs114995432	chr10:57006966-57006967	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs184994552	chr10:57007016-57007017	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs560960189	chr10:57007018-57007019	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs574257144	chr10:57007020-57007021	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs139316763	chr10:57007028-57007029	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs190245902	chr10:57007122-57007123	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs559966164	chr10:57007137-57007138	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs531987934	chr10:57007139-57007140	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs55810644	chr10:57007152-57007153	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Obesity	21956041	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16272173	CNVD
Metanephric adenoma	20802469	CNVD
Autism	20841430	CNVD
Mental retardation	17124404	CNVD
Epilepsy	20923578	CNVD
Prostate cancer	16573809	CNVD
Schizophrenia	19329560	CNVD
Heart failure	18772530	CNVD
Heart failure	18854381	CNVD
Hyperglycemia	19060297	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Glioblastoma multiforme	22286061	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Usher syndrome	20538994	CNVD
Glioblastoma multiforme	17002787	CNVD
Autism	20858243	CNVD
Breast cancer	22522925	CNVD
Usher type I cohort	17277737	CNVD
Usher type I cohort	21436283	CNVD
Leukemia	21357790	CNVD
Medulloblastoma	22832581	CNVD
Chronic lymphocytic leukemia	21546498	CNVD

Chromatin state (count:50 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:57005400-57005600	Enhancers	HUVEC	blood vessel
2	chr10:57005600-57005800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
3	chr10:57005600-57006000	Active TSS	Colonic Mucosa	Colon
4	chr10:57005600-57006000	Enhancers	Ovary	ovary
5	chr10:57005600-57006000	Flanking Active TSS	HUVEC	blood vessel
6	chr10:57005600-57006200	Active TSS	Stomach Smooth Muscle	stomach
7	chr10:57005600-57006200	Active TSS	NHDF-Ad	bronchial
8	chr10:57005600-57006400	Active TSS	Duodenum Smooth Muscle	Duodenum
9	chr10:57005800-57006200	Active TSS	Fetal Adrenal Gland	Adrenal Gland
10	chr10:57006000-57006400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr10:57006000-57006400	Active TSS	HUVEC	blood vessel
12	chr10:57006200-57007200	Weak transcription	Stomach Smooth Muscle	stomach
13	chr10:57006800-57007600	Enhancers	Fetal Lung	lung
14	chr10:57007200-57007400	Enhancers	Stomach Smooth Muscle	stomach
15	chr10:57019800-57020600	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr10:57019800-57020800	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr10:57019800-57020800	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr10:57020200-57021000	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr10:57020600-57026400	Weak transcription	HUES64 Cell Line	embryonic stem cell
20	chr10:57020800-57021000	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr10:57020800-57024000	Weak transcription	HUES48 Cell Line	embryonic stem cell
22	chr10:57021000-57026200	Weak transcription	HUES6 Cell Line	embryonic stem cell
23	chr10:57021000-57026600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
24	chr10:57022800-57023400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr10:57022800-57026400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
26	chr10:57023000-57023400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr10:57023000-57023400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
28	chr10:57024000-57024200	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr10:57024000-57024200	Enhancers	Stomach Smooth Muscle	stomach
30	chr10:57024000-57024400	Enhancers	HUES48 Cell Line	embryonic stem cell
31	chr10:57024200-57026200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
32	chr10:57024400-57024600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr10:57024400-57026200	Weak transcription	HUES48 Cell Line	embryonic stem cell
34	chr10:57024600-57026200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
35	chr10:57026200-57026800	Enhancers	ES-I3 Cell Line	embryonic stem cell
36	chr10:57026200-57026800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
37	chr10:57026200-57026800	Enhancers	HUES6 Cell Line	embryonic stem cell
38	chr10:57026200-57027000	Enhancers	HUES48 Cell Line	embryonic stem cell
39	chr10:57026200-57027000	Enhancers	iPS-20b Cell Line	embryonic stem cell
40	chr10:57026200-57027000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr10:57026400-57026800	Enhancers	H9 Cell Line	embryonic stem cell
42	chr10:57026400-57026800	Enhancers	HUES64 Cell Line	embryonic stem cell
43	chr10:57026400-57026800	Enhancers	iPS-15b Cell Line	embryonic stem cell
44	chr10:57026400-57026800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr10:57026400-57027000	Enhancers	H1 Cell Line	embryonic stem cell
46	chr10:57026600-57026800	Enhancers	iPS-18 Cell Line	embryonic stem cell
47	chr10:57032400-57034000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr10:57032400-57034600	Enhancers	Fetal Brain Male	brain
49	chr10:57032600-57034600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr10:57033200-57033800	Enhancers	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links